Strumento inattivo

Altre lingue Quanta, Inc. Other OTC

Azioni

QNTA

US74766N1081

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Quanta and Medolife Rx Provide Updates on Activities and Plans	05/12/22
QUANTA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	17/08/22
QUANTA INC : Other Events (form 8-K)	27/06/22
QUANTA INC : Entry into a Material Definitive Agreement (form 8-K)	16/06/22
Medolife Rx in Discussions with a Major Infomercial Agency and Receives Exceptionally Positive Product Reviews	01/06/22
QUANTA INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23/05/22
Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	23/05/22
Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions	04/05/22
QUANTA INC : Regulation FD Disclosure (form 8-K)	04/05/22
QUANTA INC : Changes in Registrant's Certifying Accountant (form 8-K)	28/04/22
QUANTA INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	15/04/22
Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/04/22
Medolife Rx Announces Changes to Management and Improvements to AELIA’s Marketing Efforts	07/02/22
Medolife Rx Announces Changes to Management and Improvements to AELIA’s Marketing Efforts	07/02/22
Medolife Rx Submits Final Clinical Trial Data for Escozine Approval as a COVID-19 Treatment in The Dominican Republic	19/01/22
Medolife Rx Presents Its Venom-To-Drug Development Projects at an International Conference Held in the Dominican Republic	11/01/22
Medolife Rx Announces Results of Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor Products	02/12/21
QUANTA INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)	23/11/21
QUANTA INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22/11/21
Quanta, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22/11/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Quanta, Inc. Other OTC

Azioni

QNTA

US74766N1081

Altre lingue

Filtri